Grover K Yamane1. 1. Epidemiology Services Branch, Air Force Institute for Operational Health, 2513 Kennedy Circle, Brooks City-Base, TX 78235-5116, USA. grover.yamane@brooks.af.mil
Abstract
BACKGROUND: Cancer incidence in U.S. Air Force active duty (AFAD) personnel is unknown. Defining the epidemiology may support more effective prevention and clinical services. METHODS: Standardized incidence ratios (SIRs) for invasive cancer in AFAD personnel during 1989-2002 were determined using U.S. national incidence rates as the reference. SIRs were adjusted for age and race. Cutaneous squamous and basal cell carcinomas (CAs) were excluded. RESULTS: There were 2750 cases: 1986 in men and 764 in women. The all-cancers SIRs were for men, 0.50 (95% CI: 0.48-0.53), and for women, 0.96 (95% CI: 0.89-1.03). Among men, the 10 most frequent cancers (77.6% of total) were, in descending order: melanoma; testicular CA; prostate CA; non-Hodgkin lymphoma; follicular/papillary thyroid CA; Hodgkin's Disease; colorectal CA; brain neuroepithelial CA; and (tied) bladder CA and oral squamous cell CA. Among women, the 10 most frequent cancers (88.1% of total) were, in descending order: breast CA; cervical CA; follicular/papillary thyroid CA; melanoma; Hodgkin's Disease; colorectal CA; (tied) non-Hodgkin lymphoma and ovarian epithelial CA; vulvar CA; and (tied) brain neuroepithelial CA and oral squamous cell CA. Compared with the U.S. population, cancer type-specific SIRs were significantly increased for cervical CA, prostate CA, and vulvar CA (range, 1.44-3.54). SIRs were significantly decreased for bladder CA (men), brain neuroepithelial CA, colorectal CA (men), Hodgkin's Disease (men), non-Hodgkin lymphoma, oral squamous cell CA (men), and testicular CA (range, 0.31-0.68). The remaining SIRs were not significantly different from unity. CONCLUSIONS: The cancer experience of the AFAD population differs substantially from that of the U.S. population.
BACKGROUND:Cancer incidence in U.S. Air Force active duty (AFAD) personnel is unknown. Defining the epidemiology may support more effective prevention and clinical services. METHODS: Standardized incidence ratios (SIRs) for invasive cancer in AFAD personnel during 1989-2002 were determined using U.S. national incidence rates as the reference. SIRs were adjusted for age and race. Cutaneous squamous and basal cell carcinomas (CAs) were excluded. RESULTS: There were 2750 cases: 1986 in men and 764 in women. The all-cancers SIRs were for men, 0.50 (95% CI: 0.48-0.53), and for women, 0.96 (95% CI: 0.89-1.03). Among men, the 10 most frequent cancers (77.6% of total) were, in descending order: melanoma; testicular CA; prostate CA; non-Hodgkin lymphoma; follicular/papillary thyroid CA; Hodgkin's Disease; colorectal CA; brain neuroepithelial CA; and (tied) bladder CA and oral squamous cell CA. Among women, the 10 most frequent cancers (88.1% of total) were, in descending order: breast CA; cervical CA; follicular/papillary thyroid CA; melanoma; Hodgkin's Disease; colorectal CA; (tied) non-Hodgkin lymphoma and ovarian epithelial CA; vulvar CA; and (tied) brain neuroepithelial CA and oral squamous cell CA. Compared with the U.S. population, cancer type-specific SIRs were significantly increased for cervical CA, prostate CA, and vulvar CA (range, 1.44-3.54). SIRs were significantly decreased for bladder CA (men), brain neuroepithelial CA, colorectal CA (men), Hodgkin's Disease (men), non-Hodgkin lymphoma, oral squamous cell CA (men), and testicular CA (range, 0.31-0.68). The remaining SIRs were not significantly different from unity. CONCLUSIONS: The cancer experience of the AFAD population differs substantially from that of the U.S. population.
Authors: Deborah J del Junco; Erin E Fox; Sharon Cooper; Marc Goldhagen; Erik Koda; David Rogers; Edith Canby-Hagino; Jeri Kim; Curtis Pettaway; Douglas D Boyd Journal: J Urol Date: 2011-04-15 Impact factor: 7.450
Authors: Lindsey R Enewold; Jing Zhou; Susan S Devesa; Amy Berrington de Gonzalez; William F Anderson; Shelia H Zahm; Alexander Stojadinovic; George E Peoples; Aizenhawar J Marrogi; John F Potter; Katherine A McGlynn; Kangmin Zhu Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-09-13 Impact factor: 4.254
Authors: Jennifer G Powers; Neelam A Patel; Edward M Powers; Jonathan E Mayer; George P Stricklin; Alan C Geller Journal: J Invest Dermatol Date: 2015-06-25 Impact factor: 8.551
Authors: Jing Zhou; Lindsey Enewold; Shelia H Zahm; Susan S Devesa; William F Anderson; John F Potter; Katherine A McGlynn; Kangmin Zhu Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-12-08 Impact factor: 4.254
Authors: David Rogers; Douglas D Boyd; Erin E Fox; Sharon Cooper; Marc Goldhagen; Yu Shen; Deborah J Del Junco Journal: Aviat Space Environ Med Date: 2011-11
Authors: Kangmin Zhu; Susan S Devesa; Hongyu Wu; Shelia Hoar Zahm; Ismail Jatoi; William F Anderson; George E Peoples; Larry G Maxwell; Elder Granger; John F Potter; Katherine A McGlynn Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-06 Impact factor: 4.254